Midostaurin is a multi-targeted protein kinase inhibitor used as a therapeutic treatment for conditions including acute myeloid leukemia, myelodysplastic syndrome, and advanced systemic mastocytosis. This… Read more
![Chemical structure of (5S,6R,7R,9R)-7-((Benzoyloxy)(methyl)amino)-6-methoxy-5-methyl-6,7,8,9,15,16-hexahydro-5H,14H-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-14-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2573122-12-8-5S6R7R9R-7-Benzoyloxymethylamino-6-methoxy-5-methyl-67891516-hexahydro-5H14H-17-oxa-4b9a15-triaza-59-methanodibenzobhcyclononajklcyclopen.png&w=3840&q=75)










![Chemical structure of N-((5R,6S,7S,9R)-6-Methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-7-yl)-N-methylbenzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F666838-30-8-N-5R6S7S9R-6-Methoxy-5-methyl-14-oxo-67891516-hexahydro-5H14H-17-oxa-4b9a15-triaza-59-methanodibenzobhcyclononajklcyclopentae-as-indacen-7.png&w=3840&q=75)
![Chemical structure of N-((5S,6R,7R,9R,16S)-16-Hydroxy-6-methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-7-yl)-N-methylbenzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F945260-14-0-N-5S6R7R9R16S-16-Hydroxy-6-methoxy-5-methyl-14-oxo-67891516-hexahydro-5H14H-17-oxa-4b9a15-triaza-59-methanodibenzobhcyclononajklcyclopenta.png&w=3840&q=75)
![Chemical structure of N-((5S,6R,7R,9S)-6-Methoxy-5-methyl-14,16-dioxo-6,7,8,9,15,16-hexahydro-5H,14H-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-7-yl)-N-methylbenzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F154589-96-5-N-5S6R7R9S-6-Methoxy-5-methyl-1416-dioxo-67891516-hexahydro-5H14H-17-oxa-4b9a15-triaza-59-methanodibenzobhcyclononajklcyclopentae-as-indac.png&w=3840&q=75)





Midostaurin is a multi-targeted protein kinase inhibitor used as a therapeutic treatment for conditions including acute myeloid leukemia, myelodysplastic syndrome, and advanced systemic mastocytosis. This category provides comprehensive analytical support for researchers and pharmaceutical laboratories through a range of high-quality Midostaurin reference standards. Our collection includes identified impurities, such as 7-hydroxystaurosporine, N-desmethylmidostaurin, and various hydroxy derivatives, which are essential for rigorous impurity profiling and method validation. To further assist with precise quantitative analysis and complex pharmacokinetic studies, we offer a selection of stable isotope labelled compounds, including deuterated and 13C-labelled analogues. These reference materials are vital tools for ensuring consistent quality control and maintaining regulatory compliance throughout the pharmaceutical development and manufacturing process.